MEG3 and chronic myelogenous leukemia, BCR-ABL1 positive: Inhibition of cell proliferation and metastasis and prompted apoptosis of resistant CML cells could be initiated through forced expression of MEG3 interacting with its mediators miR-184 and miR-147 [176,177].